OWCM
REGN icon

One Wealth Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

One Wealth Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998K Buy
1,600
+828
+107% +$564K 0.28% 51
2026
Q1 		$565K Buy
772
+308
+66% +$236K 0.25% 50
2025
Q4 		$358K Buy
+464
New +$315K 0.15% 85

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

One Wealth Capital Management's REGN Position: Q2 2026 in Review

One Wealth Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 107% in Q2 2026, buying an estimated $564K and bringing the position to 1,600 shares worth $998K. The position accounts for 0.28% of the portfolio, ranked #51.

One Wealth Capital Management first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • One Wealth Capital Management held 1,600 shares of Regeneron Pharmaceuticals worth $998K as of Q2 2026.
  • One Wealth Capital Management bought 828 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $564K.
  • Regeneron Pharmaceuticals made up 0.28% of One Wealth Capital Management's portfolio in Q2 2026, its #51 holding.
  • One Wealth Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on One Wealth Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.